RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $2,553,000 | +76.6% | 284,598 | +5.7% | 0.00% | +100.0% |
| Q2 2016 | $1,446,000 | +25.4% | 269,356 | +7.5% | 0.00% | 0.0% |
| Q1 2016 | $1,153,000 | -14.7% | 250,575 | -3.6% | 0.00% | 0.0% |
| Q4 2015 | $1,351,000 | -26.3% | 259,806 | -14.3% | 0.00% | 0.0% |
| Q3 2015 | $1,834,000 | -58.6% | 303,071 | +7.9% | 0.00% | -66.7% |
| Q2 2015 | $4,435,000 | +84.6% | 280,894 | +27.1% | 0.00% | +50.0% |
| Q1 2015 | $2,402,000 | +3.3% | 220,975 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $2,325,000 | +4.0% | 220,975 | -5.2% | 0.00% | 0.0% |
| Q3 2014 | $2,235,000 | -19.7% | 233,048 | -3.3% | 0.00% | 0.0% |
| Q2 2014 | $2,783,000 | +18.8% | 240,982 | +2.8% | 0.00% | 0.0% |
| Q1 2014 | $2,343,000 | -24.9% | 234,344 | -2.2% | 0.00% | 0.0% |
| Q4 2013 | $3,119,000 | -10.3% | 239,584 | +2.9% | 0.00% | -33.3% |
| Q3 2013 | $3,479,000 | +69.0% | 232,884 | +5.7% | 0.00% | +50.0% |
| Q2 2013 | $2,059,000 | – | 220,223 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parametrica Management Ltd | 16,355 | $244,000 | 3.04% |
| EAM Investors, LLC | 175,761 | $2,626,000 | 0.52% |
| Tekla Capital Management LLC | 110,000 | $1,643,000 | 0.18% |
| Jane Street Holding, LLC | 447,456 | $6,676,000 | 0.08% |
| A.R.T. Advisors, LLC | 95,164 | $1,419,000 | 0.08% |
| CREDIT SUISSE AG/ | 5,079,886 | $75,792,000 | 0.08% |
| NOMURA HOLDINGS INC | 736,362 | $10,936,000 | 0.07% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,000,000 | $14,920,000 | 0.04% |
| ROYAL BANK OF CANADA | 2,971,616 | $44,337,000 | 0.03% |
| LORD, ABBETT & CO. LLC | 721,849 | $10,784,000 | 0.02% |